Volume 11, Number 10—October 2005
Research
New Measles Genotype, Uganda
Table 2
Genotype* | Nucleoprotein gene (range)† | Hemagglutinin gene‡ |
---|---|---|
A | 5.1–6.2 | 2.2 |
B1 | 6.8–8.2 | 3.2 |
B2 | 6.4–7.7 | 4.0 |
B3-NY USA/94 | 6.6–7.9 | 3.8 |
C1 | 5.1–5.9 | 2.3 |
C2-Erlangen Due/90 | 8.6–9.9 | 3.1 |
D1 | 4.4–5.7 | 2.2 |
D2 | 3.1–4.4 | 2.6 |
D3 | 4.8–6.4 | 3.5 |
D4 | 5.5–6.4 | 3.1 |
D5-Palau BLA/93 | 4.8–6.4 | 3.1 |
D6 | 5.7–7.0 | 2.4 |
D7-Illinois USA/99 | 7.7–9.0 | 3.0 |
D8 | 5.3–6.6 | 3.0 |
D9 | 5.7–7.3 | 3.0 |
E | 5.5–6.8 | 2.9 |
F | 6.2–7.5 | 3.0 |
G1 | 7.7–9.0 | 4.2 |
G2 | 7.2–8.6 | 4.6 |
G3 | 6.8–8.2 | 5.3 |
H1 | 7.9–8.8 | 5.5 |
H2 | 7.3–9.0 | 4.6 |
*One reference sequence was used for each comparison. For a genotype with >1 reference sequence, the indicated sequence was used for comparison.
†Range of percentage nucleotide differences between all Uganda sequences and the reference sequences for the nucleoprotein gene.
‡Since we had only 2 Ugandan hemagglutinin gene sequences, the lowest percentage difference is shown. However, both percentages did not vary by >0.1%.
Page created: February 22, 2012
Page updated: February 22, 2012
Page reviewed: February 22, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.